Conference Ref: N11-8008
INHALED DRUG DELIVERY -
***FORMERLY PORTABLE INHALERS***
The last 12 to 18 months has probably seen more significant changes in the Inhaled Drug Delivery business than for a long time and that will shape it for the next 5 to 10 years. This conference will form a cornerstone in examining some of these events. This new conference has come at a very timely period in the evolution of inhaled therapies; it will provide a real opportunity to understand the current health of the inhaled delivery industry.
Register here for this event
Programme to Include:
- Trio - Products for Inhaled Drug Delivery
- Triple Therapy with Salmeterol/Fluticasone Propionate and
- Tiotropium Bromide vs Individual Components in Moderate to Severe COPD
- Balancing Risk vs Reward: A Venture Capitalist's Perspective
- Aqueous Delivery Systems: The Perfect Delivery Technology
- Technosphere® Technology: A Dry Powder Inhalation System
- Development of Loxapine and an Update on Zaleplon
- Inhaled Vaccines: Current Status and Future Challenges
- Modelling DPI Particle De-Aggregation - A New Approach
- Update on Technical and Clinical Results of the MAP Tempo Inhaler
- Inhaled Antibiotics
- The Challenges of Inhaled Chemotherapy
- A Showcase of New Inhaler Technologies
Register here for this event
Clearly this event will appeal to you if you’re looking for the following:
- A comprehensive understanding of the current Inhaled Drug Delivery Market
- Specialist knowledge on Inhaled Drug Delivery
- An opportunity to build business relationships with others in the Inhaled Drug Delivery industry
- A technology update on progress in this field
It's easy. All you’ll need to register for this event is:
- The name, email and mailing address of the person you want to attend
- Some information about you and your company
- Your card for payment or invoice details
Register here for this event
Comments from Joint Chairman Steve Nichols' re. the IDD Course
"Management Forum has been running the successful 'Portable Inhalers' conference series for 15 years. During this time major changes in formulation and delivery technologies, medicinal products, regulatory and quality requirements have occurred. These changes are such that the previous focus of 'Portable Inhalers' has to evolve into a new, bigger and better conference - Inhaled Drug Delivery (IDD. IDD will focus on current issues and technologies, with a significant contribution on the changing regulatory scene. We are very excited about this evolutionary leap and believe it will provide a much needed new approach to assist in product development knowledge and networking opportunities".
Similar Pages:
Drug Delivery Inhaled
| IDD

